Home > Income Statement > BIOCON

BIOCON
Revenue

    Back to Income Statement
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹15,262 Cr₹14,756 Cr₹11,174 Cr₹8,184 Cr₹7,143 Cr

What is the latest Revenue of BIOCON ?

The latest Revenue ratio of BIOCON is ₹15,262 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹15,262 Cr
Mar2024₹14,756 Cr
Mar2023₹11,174 Cr
Mar2022₹8,184 Cr
Mar2021₹7,143 Cr

How is Revenue of BIOCON Trending?

Years Revenue % Change
Mar2025 ₹15,262 Cr
3.43
Mar2024 ₹14,756 Cr
32.05
Mar2023 ₹11,174 Cr
36.54
Mar2022 ₹8,184 Cr
14.57
Mar2021 ₹7,143 Cr -

Compare Revenue of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹67,048.5 Cr -1.2% -3.3% 16.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,639.0 Cr 0.9% -3.1% 7.9% Stock Analytics
DIVIS LABORATORIES ₹179,647.0 Cr 2% -2.1% -0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,366.0 Cr -2.9% -0.3% 36.4% Stock Analytics
CIPLA ₹109,528.0 Cr -2.4% -3.8% -10.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,819.0 Cr -0.5% -5% -6.9% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-1.2%

-3.3%

16.8%

SENSEX

4.9%

2.8%

-6.2%


You may also like the below Video Courses